Browse > Article
http://dx.doi.org/10.4333/KPS.2007.37.1.051

Optimization of Preparation Variables for Trimyristin Solid Lipid Nanoparticles  

Choi, Mi-Hee (Department of Pharmaceutical Engineering, Woosuk University)
Lee, Mi-Kyung (Department of Pharmaceutical Engineering, Woosuk University)
Publication Information
Journal of Pharmaceutical Investigation / v.37, no.1, 2007 , pp. 51-55 More about this Journal
Abstract
Solid lipid nanoparticles (SLNs) have been regarded to behave similar to the vegetable oil emulsions because emulsions of lipid melts are formed before lipid droplets being solidified to turn into SLNs. Compared to lipid emulsion, however, it has been more difficult to obtain stable SLNs and needs more extensive considerations on stabilizer and manufacturing process. In the present study, we tried to prepare phosphatidylcholine-based trymyristin (TM) SLNs using high pressure homogenization method and optimize the manufacturing variables such as homogenization pressure, number of homogenization cycles, cooling temperature, co-stabilizer and freeze-drying with cryoprotectants. Nano-sized TM particles could be Prepared using egg Phosphatidylcholine and pegylated phospholipids ($PEG_{2000}$PE) as stabilizers. Based on the optimization study, the dispersion was manufactured by homogenization under the pressure of 100 MPa for more than 5 cycles, and solidifying the intermediately formed lipid melt droplets by dipping in liquid nitrogen followed by thawing at room temperature. In addition, TM SLNs could be freeze-dried and then redispersed easily without significant particle size changes after freeze drying with 10% and 12.5% sucrose or trehalose. The TM SLNs established in this study can be used as delivery system for drugs and cosmetics.
Keywords
Solid lipid nanoparticles; Trimyristin; High pressure homogenization; Freeze drying;
Citations & Related Records
연도 인용수 순위
  • Reference
1 J. S. Lucks, R. H. MUller, and B. Konig, B. Solid lipid nanoaprticles (SLN) - an alternative parenteral drug carrier system. Eur. J Pharm. Biopharm., 38, 33S (1992)
2 B. Siekmann and K. Westesen, Submicron-sized parenteral carrier systems based on solid lipids. Pharm. Pharmacol. Lett., 1, 123-126 (1992)
3 R. H. Muller, M. Radtke and S. A. Wissing, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations, Adv. Drug Deliv. Rev., 54 (Suppl 1), S131-55 (2002)   DOI   ScienceOn
4 B. Siekmann and K. Westesen, Submicron lipid suspensions (solid lipid nanoparticles) versus lipid nanoemulsions: similarities and differences. In Submicron emulsions in drug targeting and delivery, harwood academic publishers, edited by S. Benita., pp205-218. (1998)
5 G. Strauss, P. Schurtenberger, P. and H. Hauser, The interaction of saccharides with lipid bilayer vesicles: stabilization during freeze-thawing and freeze-drying. Biochim. Biophys. Acta, 858, 169-180 (1986)   DOI   ScienceOn
6 M. Grit and D. J. A. Crommelin, The effect of aging on the physical stability ofliposome dispersions. Chem. Phys. Lipids, 62, 113-122 (1992)   DOI   ScienceOn
7 M. F. Powell, T. Nguyen and L. Baloian, Compendium of excipients for parenteral formulations. PDA J. Pharm. Sci. Tech., 52, 238-311 (1998)
8 M. Ausborn, P. Nuhn, P. and H. Schreier, Stabilization of liposomes by freeze-thaw and lyophilization techniques: problems and opportunities. Eur. J Pharm. Biopharm., 38, 133-139 (1992)
9 C. Schwartz, J. S. Mehnert, J. S. Lucks and R. H. Muller, Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J. Control. Rel., 30, 83-96 (1994)   DOI   ScienceOn
10 R. H. Muller and E. B. Souto, Investigation ofthe factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J. Microencapsul., 23, 377-88 (2006)   DOI   ScienceOn
11 D. F. Driscoll, Lipid-injectable emulsions: 2006, Nutr. Clin. Pract., 21, 381-6 (2006)   DOI